Patent · US Active

Specific inhibitors for vascular endothelial growth factor receptors

US7875603B2 · kind B2 · utility

15Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 21, 2007
Grant dateJan 25, 2011
Priority date—
Expiry dateSep 21, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C251/86
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application describes isoindoles and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful inhibitors of VEGFR.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.